Market closed
Medifast/MED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Medifast
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Ticker
MED
Sector
Trading on
NYSE
Industry
Personal Care Products
Headquarters
Employees
634
Website
Medifast Metrics
BasicAdvanced
$192M
Market cap
6.73
P/E ratio
$2.67
EPS
1.18
Beta
$1.65
Dividend rate
36.67%
Dividend yield
Price and volume
Market cap
$192M
Beta
1.18
52-week high
$77.69
52-week low
$17.17
Average daily volume
193K
Dividend rate
$1.65
Financial strength
Current ratio
2.984
Quick ratio
2.175
Long term debt to equity
6.366
Total debt to equity
9.304
Dividend payout ratio (TTM)
125.25%
Management effectiveness
Return on assets (TTM)
6.99%
Return on equity (TTM)
15.01%
Valuation
Price to earnings (TTM)
6.733
Price to revenue (TTM)
0.255
Price to book
0.93
Price to tangible book (TTM)
0.93
Price to free cash flow (TTM)
3.609
Dividend yield (TTM)
9.17%
Forward dividend yield
36.67%
Growth
Revenue change (TTM)
-43.90%
Earnings per share change (TTM)
-77.94%
3-year revenue growth (CAGR)
-15.38%
3-year earnings per share growth (CAGR)
-40.47%
3-year dividend per share growth (CAGR)
-31.35%
What the Analysts think about Medifast
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Medifast stock.
Medifast Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Medifast Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Medifast News
AllArticlesVideos
Medifast Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Reach Out To The Schall Law Firm
Accesswire·1 week ago
The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
Accesswire·2 weeks ago
Medifast Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Medifast stock?
Medifast (MED) has a market cap of $192M as of October 11, 2024.
What is the P/E ratio for Medifast stock?
The price to earnings (P/E) ratio for Medifast (MED) stock is 6.73 as of October 11, 2024.
Does Medifast stock pay dividends?
Yes, the Medifast (MED) stock pays dividends to shareholders. As of October 11, 2024, the dividend rate is $1.65 and the yield is 36.67%. Medifast has a payout ratio of 125.25% on a trailing twelve-month basis.
When is the next Medifast dividend payment date?
The next Medifast (MED) dividend payment date is unconfirmed.
What is the beta indicator for Medifast?
Medifast (MED) has a beta rating of 1.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.